Balance Wealth
DXCM icon

Balance Wealth’s DexCom DXCM Stock Holding History

Balance Wealth’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$510 Buy
+6
New +$499 ﹤0.01% 890

Other funds holding DXCM

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Balance Wealth's DXCM Position: Q3 2026 in Review

Balance Wealth opened a new position in DexCom (DXCM) in Q3 2026: 6 shares worth $510. The stake represents ﹤0.01% of the portfolio and ranks #890 among its holdings.

863 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.

  • Balance Wealth held 6 shares of DexCom worth $510 as of Q3 2026.
  • DexCom was a new Balance Wealth position in Q3 2026.
  • DexCom made up ﹤0.01% of Balance Wealth's portfolio in Q3 2026, its #890 holding.
  • 863 funds tracked by Wall St. Rank held DexCom as of Q3 2026.

Based on Balance Wealth's 13F filing for Q3 2026, filed 27 Oct 2026.